Zacks Investment Research lowered shares of National Research (NASDAQ:NRCIA) from a hold rating to a sell rating in a report released on Wednesday.

According to Zacks, “National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska. “

Separately, BidaskClub raised shares of National Research from a hold rating to a buy rating in a research report on Friday, January 26th.

National Research (NASDAQ NRCIA) traded down $2.90 during trading hours on Wednesday, reaching $32.40. 42,800 shares of the company’s stock were exchanged, compared to its average volume of 19,332. The stock has a market cap of $864.22, a PE ratio of 62.31 and a beta of 1.54. National Research has a one year low of $16.90 and a one year high of $41.99.

In other news, CEO Michael D. Hays sold 1,602,399 shares of the stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $39.03, for a total transaction of $62,541,632.97. Following the transaction, the chief executive officer now owns 5,261,410 shares of the company’s stock, valued at $205,352,832.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 37.54% of the company’s stock.

Several hedge funds have recently modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of National Research by 3.6% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,070,194 shares of the business services provider’s stock worth $78,046,000 after purchasing an additional 71,648 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in shares of National Research by 1.3% during the third quarter. Dimensional Fund Advisors LP now owns 605,856 shares of the business services provider’s stock worth $22,841,000 after purchasing an additional 7,666 shares during the last quarter. BlackRock Inc. lifted its position in shares of National Research by 0.6% during the fourth quarter. BlackRock Inc. now owns 476,279 shares of the business services provider’s stock worth $17,765,000 after purchasing an additional 2,620 shares during the last quarter. Conestoga Capital Advisors LLC lifted its position in shares of National Research by 7.5% during the fourth quarter. Conestoga Capital Advisors LLC now owns 453,436 shares of the business services provider’s stock worth $16,913,000 after purchasing an additional 31,505 shares during the last quarter. Finally, Renaissance Technologies LLC lifted its position in shares of National Research by 27.1% during the fourth quarter. Renaissance Technologies LLC now owns 289,900 shares of the business services provider’s stock worth $10,813,000 after purchasing an additional 61,900 shares during the last quarter. 25.40% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION WARNING: This report was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of United States and international copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2018/02/15/national-research-nrcia-downgraded-by-zacks-investment-research.html.

About National Research

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.

Get a free copy of the Zacks research report on National Research (NRCIA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.